Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
This finding was not seen in people who used GLP-1 medications for shorter periods and has not been consistently confirmed across other studies
Export Compliance Support: Our regulatory experts assist you in tailoring ingredient formulations and label claims to suit your target markets, helping you mitigate the risks associated with prohibited ingredients
Brightens & Lightens Your Skin
Participants taking the highest dose of Eli Lillys new GLP-1 drug lost an average of 28.7% of their body weight in a late-stage trial, putting it on track to be a heavyweight in the crowded world of weight-loss and diabetes treatments
International note Retatrutide is also not approved in the UK, EU, Australia, Canada, or any other major market as of June 2026
US$ 25.67
US$ 21.49
US$ 28.78
US$ 27.21
